Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Клинико-ультрасонографическая оценка эффективности левоцетиризина (Гленцета) у больных экземой
Клинико-ультрасонографическая оценка эффективности левоцетиризина (Гленцета) у больных экземой
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Аннотация
Полный текст
Список литературы
1. Rathod RT, Misra D. FDC of montelukast with levocetirizine: focus on bilayer technology. J Indian Med Assoc 2009; 107 (8): 562–4.
2. Wu P, Mitchell S, Walsh GM. A new antihistamine levocetirizine inhibits eosinophil adhesion to vascular cell adhesion molecule-1 under flow conditions. Clin Exp Allergy 2005; 35 (8): 1073–9.
3. Hansen J, Klimek L, Hörmann K. Pharmacological management of allergic rhinitis in the elderly: safety issues with oral antihistamines. Drugs Aging 2005; 22 (4): 289–96.
4. Giustizieri ML, Albanesi C, Fluhr J et al. H1 histamine receptor mediates inflammatory responses in human keratinocytes. J Allergy Clin Immunol 2004; 114 (5): 1176–82.
5. Hasala H, Janka-Junttila M, Moilanen E et al. Levocetirizine and cytokine production and apoptosis of human eosinophils. Allergy Asthma Proc 2007; 28 (5): 582–91.
6. Singh-Franco D, Ghin HL, Robles GI et al. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children. Clin Ther 2009; 31 (8): 1664–87.
7. Walsh GM. A review of the role of levocetirizine as an effective therapy for allergic disease. Expert Opin Pharmacother 2008; 9 (5): 859–67.
8. Dubuske LM. Levocetirizine: The latest treatment option for allergic rhinitis and chronic idiopathic urticarial. Allergy Asthma Proc 2007; 28 (6): 724–34.
9. Simons FE. H1-antihistamine treatment in young atopic children: effect on urticaria. Early Prevention of Asthma in Atopic Children Study Group. Ann Allergy Asthma Immunol 2007; 99 (3): 261–6.
10. Dhanya NB, Rai R, Srinivas CR. Histamine 2 blocker potentiates the effects of histamine 1 blocker in suppressing histamine-induced wheal. Indian J Dermatol Venereol Leprol 2008; 74 (5): 475–7.
11. Hair PI, Scott LJ. Levocetirizine: a review of its use in the management of allergic rhinitis and skin allergies. Drugs 2006; 66 (7): 973–96.
12. Gillard M, Benedetti MS, Chatelain P et al. Histamine H1 receptor occupancy and pharmacodynamics of second generation H1-antihistamines. Inflamm Res 2005; 54 (9): 367–9.
13. Camelo-Nunes IC. New antihistamines: a critical view. J Pediatr (Rio J) 2006; 82 (Suppl. 5): S173–80.
14. Petecchia L, Serpero L. The histamine-induced enhanced expression of vascular cell adhesion molecule-1 by nasal polyp-derived fibroblasts is inhibited by levocetirizine. Am J Rhinol 2006; 20 (5): 445–9.
15. Walsh GM. Levocetirizine: an update. Curr Med Chem 2006; 13 (22): 2711–5.
2. Wu P, Mitchell S, Walsh GM. A new antihistamine levocetirizine inhibits eosinophil adhesion to vascular cell adhesion molecule-1 under flow conditions. Clin Exp Allergy 2005; 35 (8): 1073–9.
3. Hansen J, Klimek L, Hörmann K. Pharmacological management of allergic rhinitis in the elderly: safety issues with oral antihistamines. Drugs Aging 2005; 22 (4): 289–96.
4. Giustizieri ML, Albanesi C, Fluhr J et al. H1 histamine receptor mediates inflammatory responses in human keratinocytes. J Allergy Clin Immunol 2004; 114 (5): 1176–82.
5. Hasala H, Janka-Junttila M, Moilanen E et al. Levocetirizine and cytokine production and apoptosis of human eosinophils. Allergy Asthma Proc 2007; 28 (5): 582–91.
6. Singh-Franco D, Ghin HL, Robles GI et al. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children. Clin Ther 2009; 31 (8): 1664–87.
7. Walsh GM. A review of the role of levocetirizine as an effective therapy for allergic disease. Expert Opin Pharmacother 2008; 9 (5): 859–67.
8. Dubuske LM. Levocetirizine: The latest treatment option for allergic rhinitis and chronic idiopathic urticarial. Allergy Asthma Proc 2007; 28 (6): 724–34.
9. Simons FE. H1-antihistamine treatment in young atopic children: effect on urticaria. Early Prevention of Asthma in Atopic Children Study Group. Ann Allergy Asthma Immunol 2007; 99 (3): 261–6.
10. Dhanya NB, Rai R, Srinivas CR. Histamine 2 blocker potentiates the effects of histamine 1 blocker in suppressing histamine-induced wheal. Indian J Dermatol Venereol Leprol 2008; 74 (5): 475–7.
11. Hair PI, Scott LJ. Levocetirizine: a review of its use in the management of allergic rhinitis and skin allergies. Drugs 2006; 66 (7): 973–96.
12. Gillard M, Benedetti MS, Chatelain P et al. Histamine H1 receptor occupancy and pharmacodynamics of second generation H1-antihistamines. Inflamm Res 2005; 54 (9): 367–9.
13. Camelo-Nunes IC. New antihistamines: a critical view. J Pediatr (Rio J) 2006; 82 (Suppl. 5): S173–80.
14. Petecchia L, Serpero L. The histamine-induced enhanced expression of vascular cell adhesion molecule-1 by nasal polyp-derived fibroblasts is inhibited by levocetirizine. Am J Rhinol 2006; 20 (5): 445–9.
15. Walsh GM. Levocetirizine: an update. Curr Med Chem 2006; 13 (22): 2711–5.
Авторы
А.Л.Бакулев1, С.С.Кравченя1, Н.Н.Мурашкин2
1. ГОУ ВПО Саратовский ГМУ им. В.И.Разумовского Минздравсоцразвития РФ;
2. ГУЗ Краснодарский краевой клинический кожно-венерологический диспансер
1. ГОУ ВПО Саратовский ГМУ им. В.И.Разумовского Минздравсоцразвития РФ;
2. ГУЗ Краснодарский краевой клинический кожно-венерологический диспансер
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.